491 – 500 of 575
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia.
(
- Contribution to journal › Article
-
Mark
Gene expression profiling demonstrates that TGF-{beta}1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-{beta} signaling.
(
- Contribution to journal › Article
-
Mark
TGF-{beta} type II receptor deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo.
(
- Contribution to journal › Article
-
Mark
Compound developmental eye disorders following inactivation of TGFbeta signaling in neural-crest stem cells
(
- Contribution to journal › Article
-
Mark
Gene therapy: efficient targeting of hematopoietic stem cells
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The role of Smad signaling in hematopoiesis.
(
- Contribution to journal › Scientific review
-
Mark
Altered primordial germ cell migration in the absence of transforming growth factor beta signaling via ALK5
(
- Contribution to journal › Article
-
Mark
Gene Transfer to Repopulating Human CD34(+) Cells Using Amphotropic-, GALV-, or RD114-Pseudotyped HIV-1-Based Vectors from Stable Producer Cells.
(
- Contribution to journal › Article
-
Mark
Culturing of human tumor cells for use in immune gene tumor therapy
2005) World Federation of Neuro-Oncology Second Quadrennial Meeting and the Sixth Meeting of the European Association for Neuro-Oncology In Neuro-Oncology 7(3). p.371-371(
- Contribution to journal › Published meeting abstract
-
Mark
Inactivation of TGF beta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome
(
- Contribution to journal › Article